Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Routine exercise ameliorates the metabolic side-effects of treatment with the atypical antipsychotic drug olanzapine in rats
Heidi N. Boyda, Alfredo Ramos‐Miguel, Ric M. Procyshyn, et al.
The International Journal of Neuropsychopharmacology (2013) Vol. 17, Iss. 01, pp. 77-90
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses
David C. Henderson, Brenda Vincenzi, Norte García Andrea, et al.
The Lancet Psychiatry (2015) Vol. 2, Iss. 5, pp. 452-464
Closed Access | Times Cited: 251
Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain
Diana Grajales, Vítor Ferreira, Ángela M. Valverde
Cells (2019) Vol. 8, Iss. 11, pp. 1336-1336
Open Access | Times Cited: 136
Aerobic Exercise as a Tool to Improve Hippocampal Plasticity and Function in Humans: Practical Implications for Mental Health Treatment
Aaron Kandola, Joshua Hendrikse, Paul J. Lucassen, et al.
Frontiers in Human Neuroscience (2016) Vol. 10
Open Access | Times Cited: 132
Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects
Spyridon Siafis, Dimitrios Tzachanis, Myrto Samara, et al.
Current Neuropharmacology (2017) Vol. 16, Iss. 8, pp. 1210-1223
Open Access | Times Cited: 128
Multi-Target Approach for Drug Discovery against Schizophrenia
Magda Kondej, Piotr Stępnicki, Agnieszka A. Kaczor
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 3105-3105
Open Access | Times Cited: 79
Antipsychotics and glucose metabolism: how brain and body collide
Chantel Kowalchuk, L Castellani, Araba Chintoh, et al.
AJP Endocrinology and Metabolism (2018) Vol. 316, Iss. 1, pp. E1-E15
Open Access | Times Cited: 70
Exercise Treatments for Psychosis: a Review
Vijay A. Mittal, Teresa Vargas, K. Juston Osborne, et al.
Current Treatment Options in Psychiatry (2017) Vol. 4, Iss. 2, pp. 152-166
Open Access | Times Cited: 64
A Focused Review of the Metabolic Side-Effects of Clozapine
Jessica W. Y. Yuen, David D. Kim, Ric M. Procyshyn, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 53
The effects of risperidone and voluntary exercise intervention on synaptic plasticity gene expressions in the hippocampus and prefrontal cortex of juvenile female rats
Weijie Yi, Emma Sylvester, Jiamei Lian, et al.
Physiology & Behavior (2025), pp. 114879-114879
Open Access
In male rats, the ability of central insulin to suppress glucose production is impaired by olanzapine, whereas glucose uptake is left intact
Chantel Kowalchuk, Celine Teo, Virginia Wilson, et al.
Journal of Psychiatry and Neuroscience (2017) Vol. 42, Iss. 6, pp. 424-431
Open Access | Times Cited: 32
Effects of chronic exercise and treatment with the antipsychotic drug olanzapine on hippocampal volume in adult female rats
Alasdair M. Barr, Che Hsuan David Wu, Ching Wong, et al.
Neuroscience (2013) Vol. 255, pp. 147-157
Closed Access | Times Cited: 28
Differential Effects of Acute Treatment With Antipsychotic Drugs on Peripheral Catecholamines
Heidi N. Boyda, Amanzo A. Ho, Lurdes Tse, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 22
Chronic Treatment With Psilocybin Decreases Changes in Body Weight in a Rodent Model of Obesity
Joyce Y. Huang, Michelle Pham, William J. Panenka, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 13
Modulation of hypothalamic AMPK phosphorylation by olanzapine controls energy balance and body weight
Vítor Ferreira, Cintia Folgueira, María Guillén, et al.
Metabolism (2022) Vol. 137, pp. 155335-155335
Open Access | Times Cited: 13
Exercise Protects Against Olanzapine-Induced Hyperglycemia in Male C57BL/6J Mice
L Castellani, Willem T. Peppler, Paula M. Miotto, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 22
Antidiabetic-drug combination treatment for glucose intolerance in adult female rats treated acutely with olanzapine
Heidi N. Boyda, Ric M. Procyshyn, Yahya I. Asiri, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2013) Vol. 48, pp. 170-176
Closed Access | Times Cited: 22
An Evaluation of the Effects of the Novel Antipsychotic Drug Lurasidone on Glucose Tolerance and Insulin Resistance: A Comparison with Olanzapine
Claire Wu, Jessica W. Y. Yuen, Heidi N. Boyda, et al.
PLoS ONE (2014) Vol. 9, Iss. 9, pp. e107116-e107116
Open Access | Times Cited: 20
The effects of chromium picolinate on glucose and lipid metabolism in running rats
Ragıp Pala, Mehmet Akif Sari, Füsun Erten, et al.
Journal of Trace Elements in Medicine and Biology (2019) Vol. 58, pp. 126434-126434
Closed Access | Times Cited: 18
L-Carnitine supplementation increases expression of PPAR-γ and glucose transporters in skeletal muscle of chronically and acutely exercised rats
Ragıp Pala, Eyüp Genç, Mehmet Tuzcu, et al.
Cellular and Molecular Biology (2018) Vol. 64, Iss. 1, pp. 1-6
Closed Access | Times Cited: 18
Improving Metabolic and Cardiovascular Health at an Early Psychosis Intervention Program in Vancouver, Canada
Diane Fredrikson, Heidi N. Boyda, Lurdes Tse, et al.
Frontiers in Psychiatry (2014) Vol. 5
Open Access | Times Cited: 17
Exercise prevents downregulation of hippocampal presynaptic proteins following olanzapine-elicited metabolic dysregulation in rats: Distinct roles of inhibitory and excitatory terminals
Alfredo Ramos‐Miguel, William G. Honer, Heidi N. Boyda, et al.
Neuroscience (2015) Vol. 301, pp. 298-311
Closed Access | Times Cited: 16
Peripheral mechanisms of acute olanzapine induced metabolic dysfunction: A review of in vivo models and treatment approaches
Hesham Shamshoum, Kyle D. Medak, David C. Wright
Behavioural Brain Research (2020) Vol. 400, pp. 113049-113049
Closed Access | Times Cited: 15
Hypothalamic JNK1-hepatic fatty acid synthase axis mediates a metabolic rewiring that prevents hepatic steatosis in male mice treated with olanzapine via intraperitoneal: Additional effects of PTP1B inhibition
Vítor Ferreira, Cintia Folgueira, María García‐Altares, et al.
Redox Biology (2023) Vol. 63, pp. 102741-102741
Open Access | Times Cited: 5
Cardiovascular effects of acute treatment with the antipsychotic drug olanzapine in rats
Joanne Y.T. Leung, Catherine C.Y. Pang, Ric M. Procyshyn, et al.
Vascular Pharmacology (2014) Vol. 62, Iss. 3, pp. 143-149
Closed Access | Times Cited: 12
Gamma‐aminobutyric acid supplementation improves olanzapine‐induced insulin resistance by inhibiting macrophage infiltration in mice subcutaneous adipose tissue
Lulu Ren, Lingling Xuan, Anning Li, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 7, pp. 2695-2705
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top